TLX Telix Pharmaceuticals Limited logo

TLX Telix Pharmaceuticals Limited

Healthcare
$9.57+1.06%ClosedMarket Cap: $3.24B

As of 2026-05-26

Insider Statistics (Q4 2010)

Acquisitions

0

Dispositions

1

Buy/Sell Ratio

0.00

Net Shares

-500

Shares Acquired

0

Shares Disposed

500

Total Bought ($)

$0.00

Total Sold ($)

$0.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Mon May 18Rivas Mariadirector: Sell0$0.000
Mon May 18Jellison William Rdirector: Sell0$0.000
Mon May 18GILL DAVID Ndirector: Sell0$0.000
Wed May 06Behrenbruch Christiandirector, officer: MD & Group CEOBuy34,500$14.4820,709,500
Wed May 06Behrenbruch Christiandirector, officer: MD & Group CEOBuy33,435$14.8720,742,935
Wed Apr 01Smith Darren Charltonofficer: Group Chief Financial OfficerSell1,111$0.0011,921
Wed Apr 01Smith Darren Charltonofficer: Group Chief Financial OfficerSell88,497$6.900
Wed Apr 01Smith Darren Charltonofficer: Group Chief Financial OfficerSell32,463$6.150
Wed Apr 01Smith Darren Charltonofficer: Group Chief Financial OfficerSell14,741$0.000
Wed Apr 01Smith Darren Charltonofficer: Group Chief Financial OfficerSell0$0.0010,810
Wed Apr 01Cade David Normanofficer: Group Chief Medical OfficerSell84,293$6.900
Wed Apr 01Cade David Normanofficer: Group Chief Medical OfficerSell78,189$4.950
Wed Apr 01Cade David Normanofficer: Group Chief Medical OfficerSell11,486$0.000
Wed Apr 01Cade David Normanofficer: Group Chief Medical OfficerSell0$0.00373,133
Wed Mar 18Skinner Jann ElizabethdirectorSell0$0.00595,000